¶Ù°ùÌý²Ñ²¹°ù°ìÌý¸é¾±³¦³ó²¹°ù»å²õ´Ç²Ô BSc , MSc , MBA, PhD
Chief Executive Officer of the National Biofilms Innovation Centre
- Related links
Dr Mark Richardson joined the ºÚÁÏÉç from the Medical Device Industry (Smith and Nephew Plc) in December 2017 to lead the newly formed National Biofilms Innovation Centre (NBIC). NBIC is a BBSRC and Innovate UK Innovation Knowledge Centre (IKC) formed along with a consortium of other UK Universities including Liverpool, Nottingham, Edinburgh, Queen's University Belfast, Dundee, Manchester, Leeds, Birmingham, Swansea, University of the West of England, Plymouth, Portsmouth, Imperial College London and Cambridge. The NBIC has wide-ranging industrial and academic links both nationally and internationally.
Career History
2017-present:
CEO of NBIC. Biological Sciences, ºÚÁÏÉç, UK.
2009- 2016:
VP of Research and Technology, Smith and Nephew Wound Management. Hull , UK.
2001-2009:
VP Innovation, Smith and Nephew Wound Management. Hull , UK.
1997-2001:
Global Head of R&D Smith and Nephew Wound Management. Hull, UK.
Academic qualifications
1976-1979:
BSc(Hons) Microbiology. Leeds University, UK.
1979-1980:
MSc Brewing Science. Birmingham University, UK.
1980-1982:
PhD Biochemistry. Birmingham University, UK.
1990-1994:
MBA. Open University, UK.